Company Email Format

Kayothera

Biotechnology Research Seattle, Washington, United States 6 employees

Employees: 6

kayothera.com LinkedIn Crunchbase

Kayothera Overview

Headquarters: Seattle, Washington, United States
Phone Number: Available in AeroLeads
Website: kayothera.com
Industry: Biotechnology Research
Employees: 6
Founded: 2019
Funding: 5.2M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Kayothera

Kayothera specializes in inhibiting two of the last remaining nuclear receptors pathways to be drugged – the retinoid and rexinoid nuclear receptors. These pathways are clinically validated to drive adverse cardiometabolic and cancer outcomes, yet have no available inhibitors – until now. Kayothera’s unique approach blocks the formation of the retinoid or rexinoid nuclear ligands with novel, orally-available small molecules that have proven to be safe and effective medicines. We are developing these medicines to provide patients with new options for managing diabetes, obesity and cancer.

Kayothera Contact Details

People in AeroLeads: 4

Kayothera Org Chart

Sample employees and titles

Name	Title	Location	Contact
Que Liu	Chief Medical Officer at Arnatar	San Diego, California, United States	View
Merika Koday, Phd	Life Sciences Investor & Leader		View
Mark Esposito, Ph.d	Founder & Cso at Kayothera		View
Paul Sekhri			View